Form 4: Clover Health CEO Andrew Toy Reports Tax-Related Stock Disposal

Andrew Toy, CEO of Clover Health, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Summary

• On July 1, 2024, Andrew Toy, the CEO of Clover Health, disposed of 308,341 shares of Class A Common Stock to cover tax obligations.
• This disposal was a result of the vesting of 6.25% of restricted stock units (RSUs) granted to Mr. Toy on January 1, 2023.
• The shares were sold at a price of $1.2.
• Following the transaction, Mr. Toy beneficially owns 10,196,029 shares of Class A Common Stock.
• The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date on January 1, 2027, contingent upon continued service.

Sentiment

Score: 5

Explanation: This is a routine transaction related to executive compensation and tax obligations, and does not indicate a significant positive or negative sentiment.

Future Outlook

The remaining RSUs will vest quarterly in equal installments of 6.25% until January 1, 2027, contingent upon continued service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a standard practice of covering tax obligations related to equity compensation.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units (RSUs) that vest over time.
• The vesting schedule of 6.25% quarterly is a fairly standard vesting schedule.
• Similar to other companies, Clover Health's executives are required to disclose transactions involving the company's stock.

Key Dates